SCHEMBL25865147

SCHEMBL25865147

O=c1oc2ccc(-c3ccc(OC(F)(F)F)cc3)nc2n1Cc1ccccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 1/20 0.42
SCN5A Q14524 7/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
MET P08581 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
BACE1 P56817 1/20 0.37
TNIK Q9UKE5 1/20 0.37
GRIN2B Q13224 1/20 0.37
SCN9A Q15858 4/20 0.36
KCNH2 Q12809 3/20 0.36
SCN2A Q99250 2/20 0.36
MMP1 P03956 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22314544 0.87 SCN5A (0.39) SCN5AKDM4EALDH1A1NPC1GAA
SCHEMBL22314994 0.87 SCN5A (0.38) SCN5AKDM4EALDH1A1NPC1GAA
SCHEMBL22314991 0.83 SCN5A (0.42) SCN5AKDM4EALDH1A1NPC1GAA
SCHEMBL22314548 0.82 SCN5A (0.43) SCN5AKDM4EALDH1A1NPC1GAA
SCHEMBL25865133 0.82 TNIK (0.43) SCN5ATNIKGRIN2BSCN9AKCNH2
SCHEMBL25865172 0.82 SCN5A (0.41) SCN5AKDM4EALDH1A1NPC1GAA
SCHEMBL22314922 0.82 TP53 (0.43) SCN5ATNIKGRIN2BSCN2ASCN1A
SCHEMBL22314514 0.81 SCN5A (0.45) SCN5AGRIN2B
SCHEMBL22314211 0.81 SCN5A (0.40) SCN5AKDM4EALDH1A1NPC1GAA
SCHEMBL22314545 0.81 SCN5A (0.40) SCN5AKDM4EALDH1A1NPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219938-A1 COMPOUNDS AND THEIR METHODS OF USE PRAXIS PREC MEDICINES INC (US) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219938-A1 COMPOUNDS AND THEIR METHODS OF USE SCN1A, SCN3A, SCN1B PDE5A 1054/4885SCN5A 8/4885KDM4E 2066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.